Winner announcement date: 30 April 2024

Dear Colleagues,

We are pleased to announce the “IJDDP 2024 Best Paper Award” for research and review articles published in IJDDP from 1 July 2022 to 31 December 2023. Two review and two research article will each receive an award. The papers will be selected after a thorough evaluation by the journal's Award Committee, led by its Editor-in-Chief, Prof. Dr. Xin Wang, and the winners will be announced in April 2024.

Eligibility for the Award:

– Papers published in IJDDP from 1 July 2022 to 31 December 2023;

– Open to all career levels;

Selection Criteria:

The papers will be selected by the journal's Award Committee according to the following criteria:

– Scientific merit and broad impact;

– Originality of the research objectives and/or the ideas presented;

– Creativity of the study design or uniqueness of the approaches and concepts;

– Clarity of presentation;

– Citations and downloads.

Prizes:

– Two review award: AUD 1000 for each paper;

– Two research article award: AUD 1000 for each paper;

– Each winner will also receive an electronic certificate.

The winners will be announced on the journal's website at the end of April 2024.

Kind regards,

IJDDP Editorial Office

——  Winners  ——

Two Reviews:

Recent Clinical Successes in Liposomal Nanomedicines
By Wenjie Gu, Gavin P. Andrews, and Yiwei Tian
International Journal of Drug Discovery and Pharmacology 2023, 2(1), 52–59;
doi: 10.53941/ijddp.0201009

Nanoparticle-based Drug Delivery System for Post Myocardial Infarction Management
By Minxuan Liu, Chiara Ramponi, Xiaoxue Fan, Xinzhuang Zhang, Liang Cao, Zhenzhong Wang, and Wei Xiao
International Journal of Drug Discovery and Pharmacology 2022, 1(1), 11;
doi: 10.53941/ijddp.v1i1.171

Two Articles:

23-Hydroxybetulinic Acid, A Natural Compound, Alleviates DSS-induced Colitis by Regulating NF-κB Signaling
By Shuangli Xiang, Miaojuan Wang, and Xiuping Chen
International Journal of Drug Discovery and Pharmacology 2023, 2(1), 17–28;
doi: 10.53941/ijddp.0201007

Metformin Inhibits Autophagy, Mitophagy and Antagonizes Doxorubicin-Induced Cardiomyocyte Death
By Jennifer Van, Younghee Hahn, Brett Silverstein, Cairong Li, Fei Cai, Jia Wei, Lokesh Katiki, Puja Mehta, Katherine Livatova, Jaclyn DelPozzo, Tamayo Kobayashi, Yuan Huang, Satoru Kobayashi, and Qiangrong Liang
International Journal of Drug Discovery and Pharmacology 2023, 2(1), 37–51;
doi: 10.53941/ijddp.0201004

PDF